[BEIJING] China will use a Roche Holding AG arthritis drug to treat some coronavirus patients in severe conditions, health authorities said on Wednesday, as the country seeks to build up treatment...

[ZURICH] Roche entered into a US$1.15 billion licensing agreement with Sarepta Therapeutics to obtain the right to launch and commercialise Sarepta's investigational gene therapy for Duchenne...

[ZURICH] Roche extended its offer to buy Spark Therapeutics on Monday, this time until Oct 30, as US and British regulators continue to scrutinize the Swiss drugmaker's US$4.3 billion oft-delayed...

[ZURICH] Swiss drugmaker Roche's push into personalised cancer medicines hit a milestone on Tuesday with Japanese approval of a new drug, Rozlytrek, that targets patients who must be identified...

[ZURICH] Swiss pharmaceuticals giant Roche said Monday it reached a deal worth US$4.3 billion  to buy US group Spark Therapeutics, which specialises in the development of gene therapy drugs.

SWISS drugmaker Roche said on Tuesday its Tecentriq medicine will get a speedy review by US regulators in a tough-to-treat form of breast cancer, as it seeks to be the first company to have its...

ROCHE Holding AG's old guard of blockbuster medicines held their own against a new wave of cheaper copycats during the third quarter....

[ZURICH] Swiss drugmaker Roche upped its bet on personalised cancer treatment on Monday, saying it is now ready to sell a blood test around the world that can identify common gene mutations from...

ROCHE faces a fresh row over drug pricing in Britain, following a decision by the body responsible for medicine use within the state health service not to approve its drug Ocrevus for treating a...

LONDON, Sept 10 (Reuters) - Roche faces a fresh row over drug pricing in Britain, following a decision by the body responsible for medicine use within the state health service not to approve its...